Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence

NCT07443774 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT07443774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07443774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
May 26, 2026
Completion date
December 31, 2031
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abemaciclib, breast cancer, early breast cancer, endocrine therapy, er+ breast cancer, ribociclib